Assogenerics: equivalents do not 'take off', at 17% market share
Doctors complain of a lack of knowledge of the products due to the fact that the pharmaceutical companies of generics provide little information. Milillo: "... if we are not thoroughly informed about the drug, we prefer not to prescribe it". Assogenerici replies that it is a choice to provide little medical-scientific information...
Related news: http://www.federaisf.org/Start/HDefault.aspx?Newsid=7301
